Circ Cardiovasc Interv

Slides:

Advertisements

Similar presentations

The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.

Advertisements

on behalf of the TOTAL Investigators

University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.

Is PCI necessary for AMI related artery with TIMI 3 flow ? Donghoon Choi Yonsei Cardiovascular Center Yonsei University College of Medicine.

The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi.

Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.

Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:

Subgroup analyses for mortality after treatment with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). LAD, left anterior.

Figure 2 Kaplan–Meier estimates of event-free survival (survival to the combined endpoint). From: Long-term outcomes of patients with acute myocardial.

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Successful CTO PCI Associated with Lower Mortality Risk

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Mortality Related to Periprocedural MI in CTO-PCI

Circ Cardiovasc Interv

Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.

Spontaneous Coronary Artery Dissection

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Sex-Related Differences in Fractional Flow Reserve–Guided Treatment

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Circ Cardiovasc Interv

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.

Circ Cardiovasc Interv

Pulse Pressure and Resistance Artery Structure in the Elderly

Circ Cardiovasc Interv

Circ Cardiovasc Imaging

Catheter-Based Treatment of Coronary Artery Disease

Volume 8, Issue 4, Pages (April 2011)

STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Baseline characteristics of patients

European Society of Cardiology 2003

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 PCI strategies in patients with STEMI and multivessel disease

NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,

Volume 8, Issue 4, Pages (April 2011)

Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.

John A. Bittl et al. JACC 2016;68:

P. Michael Grossman et al. JCIN 2009;2:

Takumi Higuma et al. JCIN 2016;9:

Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. There.

(A) Meta-analysis of repeat revascularisation in randomised trials.

Nat. Rev. Cardiol. doi: /nrcardio

Dye strongly persistent

Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction Salman A. Haq, MD, John F. Heitner, MD, Terrence J.

Evolution of Myocardial Blush after MI

From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.

Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.

Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled.

Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex Naji Kholaif,

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Ticagrelor versus prasugrel; risk ratio with 95% CIs for the primary composite end point, primary composite end point in those undergoing PCI, myocardial.

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,

Forest plot illustrating the risk ratio of myocardial infarction

FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.

Presentation transcript:

Circ Cardiovasc Interv Operator Versus Core Laboratory Assessment of Angiographic Reperfusion Markers in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction by Sorin J. Brener, Ecaterina Cristea, Alexandra J. Lansky, Martin Fahy, Roxana Mehran, and Gregg W. Stone Circ Cardiovasc Interv Volume 5(4):563-569 August 14, 2012 Copyright © American Heart Association, Inc. All rights reserved.

A, Pre-percutaneous coronary intervention (PCI) Thrombolysis in Myocardial Infarction (TIMI) flow grade; B, Post-PCI TIMI flow grade. A, Pre-percutaneous coronary intervention (PCI) Thrombolysis in Myocardial Infarction (TIMI) flow grade; B, Post-PCI TIMI flow grade. The κ between operator (Op) and angiography core laboratory (ACL) was 0.51 (0.47 to 0.54) for pre-PCI TIMI flow and 0.35 (0.33 to 0.38) for post-PCI TIMI flow. Sorin J. Brener et al. Circ Cardiovasc Interv. 2012;5:563-569 Copyright © American Heart Association, Inc. All rights reserved.

A, Pre-percutaneous coronary intervention (PCI) densitometric myocardial blush grade (MBG); B, Post-PCI densitometric MBG. The κ between operator (Op) and angiography core laboratory (ACL) was 0.41 (0.36 to 0.47) for pre-PCI MBG and 0.20 (0.16 to 0.24) for post-PCI MBG. A, Pre-percutaneous coronary intervention (PCI) densitometric myocardial blush grade (MBG); B, Post-PCI densitometric MBG. The κ between operator (Op) and angiography core laboratory (ACL) was 0.41 (0.36 to 0.47) for pre-PCI MBG and 0.20 (0.16 to 0.24) for post-PCI MBG. Sorin J. Brener et al. Circ Cardiovasc Interv. 2012;5:563-569 Copyright © American Heart Association, Inc. All rights reserved.

3-year mortality according to final Thrombolysis in Myocardial Infarction (TIMI) flow graded by operator (Op) and angiographic core laboratory (ACL). 3-year mortality according to final Thrombolysis in Myocardial Infarction (TIMI) flow graded by operator (Op) and angiographic core laboratory (ACL). Sorin J. Brener et al. Circ Cardiovasc Interv. 2012;5:563-569 Copyright © American Heart Association, Inc. All rights reserved.

3-year mortality according to densitometric myocardial blush grade (MBG) assessed by operator (Op) and angiographic core laboratory (ACL). 3-year mortality according to densitometric myocardial blush grade (MBG) assessed by operator (Op) and angiographic core laboratory (ACL). Sorin J. Brener et al. Circ Cardiovasc Interv. 2012;5:563-569 Copyright © American Heart Association, Inc. All rights reserved.

Interaction plot of the adjusted hazard ratios for post-percutaneous coronary intervention (PCI) Thrombolysis in Myocardial Infarction (TIMI) flow. Interaction plot of the adjusted hazard ratios for post-percutaneous coronary intervention (PCI) Thrombolysis in Myocardial Infarction (TIMI) flow. ACL indicates angiography core laboratory; Op, operator. Sorin J. Brener et al. Circ Cardiovasc Interv. 2012;5:563-569 Copyright © American Heart Association, Inc. All rights reserved.

Interaction plot of the adjusted hazard ratios for post-percuatenous coronary intervention (PCI) myocardial blush grade (MBG) flow. Interaction plot of the adjusted hazard ratios for post-percuatenous coronary intervention (PCI) myocardial blush grade (MBG) flow. ACL indicates angiography core laboratory; Op, operator; MBG, myocardial blush grade. Sorin J. Brener et al. Circ Cardiovasc Interv. 2012;5:563-569 Copyright © American Heart Association, Inc. All rights reserved.